| UNAUDITED FINANCIAL RESULTS - STANDALONE | ||||||||||
| FOR THE QUARTER ENDED 30th JUNE, 2009 | ||||||||||
| Rs. Lakhs | ||||||||||
| Sl No. | Particulars | 3 months ended 30th June, 2009 | Corresponding 3 months ended in the previous year 30th June, 2008 | Previous accounting period 9 months ended 31st March, 2009 | ||||||
| Unaudited | Unaudited | Audited | ||||||||
| 1 | Net sales / Income from Operations | 8,736.74 | 6,170.70 | 25,387.36 | ||||||
| 2 | Expenditure | |||||||||
| a) (Increase)/decrease in finished goods | ||||||||||
| and work in progress | (69.18) | (276.94) | (134.33) | |||||||
| b) Consumption of Raw Materials | 5,548.04 | 3,976.42 | 15,713.29 | |||||||
| c) Manufacturing Expenses | 553.25 | 410.66 | 1,590.85 | |||||||
| d) R & D Expenses | 64.45 | 41.92 | 278.44 | |||||||
| e) Employee cost | 542.05 | 361.57 | 1,374.72 | |||||||
| f) Administrative Expenses | 316.12 | 221.23 | 956.55 | |||||||
| g) Selling & Distribution Expenses | 624.05 | 433.43 | 1,566.81 | |||||||
| h) Depreciation | 391.03 | 250.06 | 974.79 | |||||||
| i) Other expenditure | 14.24 | 9.60 | 21.79 | |||||||
| Total | 7,984.05 | 5,427.95 | 22,342.91 | |||||||
| 3 | Other Income | (8.16) | (10.91) | (85.47) | ||||||
| 4 | Profit before Interest and Exceptional Items | 760.85 | 753.66 | 3,129.92 | ||||||
| 5 | Interest and Finance charges | 490.80 | 335.55 | 1,453.83 | ||||||
| 6 | Profit after Interest but before exceptional items | 270.05 | 418.11 | 1,676.09 | ||||||
| 7 | Foreign Exchange Fluctuations (gain)/loss | (467.66) | 74.50 | 890.41 | ||||||
| 8 | Profit before taxation | 737.71 | 343.61 | 785.68 | ||||||
| 9 | Tax expense | |||||||||
| Current Tax Expense | 125.38 | 39.10 | 89.02 | |||||||
| Deferred Tax Expense | (7.52) | 30.98 | 180.25 | |||||||
| Fringe Benefit Tax | - | 3.26 | 7.88 | |||||||
| 10 | Net Profit | 619.85 | 270.27 | 508.53 | ||||||
| 11 | Paid-up share capital | 2,005.72 | 2,005.72 | 2,005.72 | ||||||
| (Face Value of Rs.10/- each) | ||||||||||
| 12 | Reserves excluding Revaluation Reserve | - | - | 16,402.74 | ||||||
| 13 | Basic Earnings per share (Rs.)* | 3.09 | 1.35 | 2.54 | ||||||
| 14 | Basic Earnings per share (Annualised) (Rs.)* | - | - | 3.39 | ||||||
| 15 | Diluted Earnings per share (Rs.)* | - | 1.25 | - | ||||||
| 16 | Public Shareholding | |||||||||
| - No. of shares | 12,616,739 | 13,547,423 | 12,620,942 | |||||||
| - Percentage of shareholding | 62.90% | 67.54% | 62.92% | |||||||
| 17 | Promoters and promoter group | |||||||||
| Shareholding | ||||||||||
| a) Pledged/Encumbered | ||||||||||
| Number of shares | 1,623,000 | - | 1,522,650 | |||||||
| Percentage of shares to promoter group | 23.63% | - | 22.19% | |||||||
| Percentage of shares to total capital | 8.09% | - | 7.59% | |||||||
| b) Non-encumbered | ||||||||||
| Number of shares | 5,244,375 | - | 5,340,522 | |||||||
| Percentage of shares to promoter group | 76.37% | - | 77.81% | |||||||
| Percentage of shares to total capital | 26.14% | - | 26.62% | |||||||
| * Not Annualised for quarter ending | ||||||||||
| NOTES : | ||||||||||
| 1) The above results were reviewed by the Audit Committee and approved by the Board at its meeting | ||||||||||
| held on 25th July , 2009 and were subjected to limited review by Statutory Auditors. | ||||||||||
| 2) Foreign Exchange Fluctuations (gain) of Rs.467.66 lakhs (net) for the quarter includes re-statement | ||||||||||
| of foreign currency loans, receivables and payables. As per the amendment dated 31-3-2009 to | ||||||||||
| Companies (Accounting Standards) Rules 2006, the enterprise is given the option either to continue | ||||||||||
| with the provisions of Accounting Standard 11 - The Effects of Changes in Foreign Exchange Rates | ||||||||||
| or capitalise exchange differences (gain/(loss)) arising on reporting of long term foreign currency | ||||||||||
| monetary items so far as they relate to the acquisition of a depreciable capital asset. The Company | ||||||||||
| has opted to continue with the existing practice of charging of exchange differences on long term | ||||||||||
| foreign currency monetary items. | ||||||||||
| 3) The company has received 20 complaints from investors during the quarter 1st April '09 to | ||||||||||
| 30th June, 09 and all were resolved. No complaints were pending from previous quarter. | ||||||||||
| 4) The Company operates only in the segment of Pharmaceuticals. | ||||||||||
| 5) Figures are regrouped wherever necessary. | ||||||||||
| for and on behalf of the Board | ||||||||||
| Place : Hyderabad | Dr.C.Nageswara Rao | |||||||||
| Date : 25.07.2009 | Chairman | |||||||||
|
|||||||||||||
| Regd Office : 2nd Floor, 3rd Block, My Home Hub | |||||||||||||
| Madhapur, Hyderabad 500 081 | |||||||||||||
| UNAUDITED FINANCIAL RESULTS - CONSOLIDATED | |||||||||||||
| FOR THE QUARTER ENDED 30th JUNE, 2009 | |||||||||||||
| Rs. Lakhs | |||||||||||||
| Sl No. | Particulars | 3 months ended 30th June, 2009 | Previous accounting period 9 months ended 31st March, 2009 | ||||||||||
| Unaudited | Audited | ||||||||||||
| 1 | Net sales / Income from Operations | 10,591.92 | 28,825.09 | ||||||||||
| 2 | Expenditure | ||||||||||||
| a) (Increase)/decrease in finished goods | |||||||||||||
| and work in progress | 204.40 | 208.60 | |||||||||||
| b) Consumption of Raw Materials | 6,355.98 | 17,442.32 | |||||||||||
| c) Manufacturing Expenses | 773.40 | 1,986.67 | |||||||||||
| d) R & D Expenses | 67.33 | 278.44 | |||||||||||
| e) Employee cost | 670.46 | 1,757.07 | |||||||||||
| f) Administrative Expenses | 370.37 | 1,108.89 | |||||||||||
| g) Selling & Distribution Expenses | 631.25 | 1,754.65 | |||||||||||
| h) Depreciation | 459.93 | 1,180.05 | |||||||||||
| i) Other expenditure | 14.24 | 21.79 | |||||||||||
| Total | 9,547.36 | 25,738.51 | |||||||||||
| 3 | Other Income | (21.90) | (102.45) | ||||||||||
| 4 | Profit before Interest and Exceptional Items | 1,066.46 | 3,189.03 | ||||||||||
| 5 | Interest and Finance charges | 519.57 | 1,570.23 | ||||||||||
| 6 | Profit after Interest but before exceptional items | 546.89 | 1,618.80 | ||||||||||
| 7 | Foreign Exchange Fluctuations (gain)/loss | (465.19) | 924.19 | ||||||||||
| 8 | Profit before taxation | 1,012.07 | 694.61 | ||||||||||
| 9 | Tax expense | ||||||||||||
| Current Tax Expense | 151.56 | 89.29 | |||||||||||
| Deferred Tax Expense | (7.52) | 180.25 | |||||||||||
| Fringe Benefit Tax | - | 7.88 | |||||||||||
| 10 | Net Profit | 868.03 | 417.20 | ||||||||||
| 11 | Paid-up share capital | 2,005.72 | 2,005.72 | ||||||||||
| (Face Value of Rs.10/- each) | |||||||||||||
| 12 | Reserves excluding Revaluation Reserve | - | 15,605.79 | ||||||||||
| 13 | Basic Earnings per share (Rs.)* | 4.21 | 2.08 | ||||||||||
| 14 | Basic Earnings per share (Annualised) (Rs.)* | - | 2.77 | ||||||||||
| 14 | Public Shareholding | ||||||||||||
| - No. of shares | 12,616,739 | 12,620,942 | |||||||||||
| - Percentage of shareholding | 62.90% | 62.92% | |||||||||||
| 15 | Promoters and promoter group | ||||||||||||
| Shareholding | |||||||||||||
| a) Pledged/Encumbered | |||||||||||||
| Number of shares | 1,623,000 | 1,522,650 | |||||||||||
| Percentage of shares to promoter group | 23.63% | 22.19% | |||||||||||
| Percentage of shares to total capital | 8.09% | 7.59% | |||||||||||
| b) Non-encumbered | |||||||||||||
| Number of shares | 5,244,375 | 5,340,522 | |||||||||||
| Percentage of shares to promoter group | 76.37% | 77.81% | |||||||||||
| Percentage of shares to total capital | 26.14% | 26.62% | |||||||||||
| * Not Annualised for quarter ending | |||||||||||||
| NOTES : | |||||||||||||
| 1) The above results were reviewed by the Audit Committee and approved by the Board at its meeting held on | |||||||||||||
| 25th July , 2009 and were subjected to limited review by Statutory Auditors. | |||||||||||||
| 2) Foreign Exchange Fluctuations (gain) of Rs.465.19 lakhs (net) for the quarter includes re-statement of foreign currency | |||||||||||||
| loans, receivables and payables. As per the amendment dated 31-3-2009 to companies (Accounting Standards) | |||||||||||||
| Rules 2006, the enterprise is given the option either to continue with the provisions of Accounting Standard 11 - The | |||||||||||||
| Effects of Changes in Foreign Exchange Rates or capitalise exchange differences (gain/(loss)) arising on reporting | |||||||||||||
| of long term foreign currency monetary items so far as they relate to the acquisition of a depreciable capital asset. | |||||||||||||
| The Company has opted to continue with the existing practice of charging of exchange differences on long term | |||||||||||||
| foreign currency monetary items. | |||||||||||||
| 3) The company has received 20 complaints from investors during the quarter 1st April '09 to 30th June, 09 and all were | |||||||||||||
| resolved. No complaints were pending from previous quarter. | |||||||||||||
| 4) The Company operates only in the segment of Pharmaceuticals. | |||||||||||||
| 5) The Company has been stating its consolidated results from the Quarter ending December, 2008. Hence figures | |||||||||||||
| for the corresponding period of previous year are not given. | |||||||||||||
| 6) Figures are regrouped wherever necessary. | |||||||||||||
| for and on behalf of the Board | |||||||||||||
| Place : Hyderabad | Dr.C.Nageswara Rao | ||||||||||||
| Date : 25.07.2009 | Chairman | ||||||||||||